Experimental tests challenge the evidence of a healthy human blood microbiome
The FEBS Journal · 2025-02 · 292 (4) · 796-808
DOI: 10.1111/febs.17362 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, online erschienen am 17.12.2024. Verfasst von Leandro Di Gloria und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental and Clinical Biomedical Sciences, University of Florence, Italy. Hauptthemen laut MEDLINE: Microbiota, Bacteria, Blood. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministry of University and Research (MUR), FONZIE project (CUP B55F21007810001), National Recovery and Resilience Plan (NRRP).
Abstract (Originalsprache)
The advent of next‐generation sequencing (NGS) technologies has made it possible to investigate microbial communities in various environments, including different sites within the human body. Therefore, the previously established belief of the sterile nature of several body sites, including human blood, has now been challenged. However, metagenomics investigation of areas with an anticipated low microbial biomass may be susceptible to misinterpretation. Here, we critically evaluate the results of 16S targeted amplicon sequencing performed on total DNA collected from healthy donors' blood samples while incorporating specific negative controls aimed at addressing potential bias to supplement and strengthen the research in this area. We prepared negative controls by increasing the initial DNA quantity through sequences that can be recognized and subsequently discarded. We found that only three organisms were sporadically present among the samples, and this was mostly attributable to bacteria ubiquitously present in laboratory reagents. Despite not fully confirming or denying the existence of healthy blood microbiota, our results suggest that living bacteria, or at least their residual DNA sequences, are not a common feature of human blood in healthy people. Finally, our study poses relevant questions on the design of controls in this research area that must be considered in order to avoid misinterpreted results that appear to contaminate current high‐throughput research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental and Clinical Biomedical Sciences, University of Florence, Italy.
- Department of Experimental and Clinical Medicine, University of Florence, Italy.
- Cardiovascular Tissue Engineering Research Unit - Centro Cardiologico Monzino, IRCCS, Italy.
- Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Florence, Italy.
ORCID-Profile: Leandro Di Gloria, Matteo Ramazzotti
Förderung
- Ministry of University and Research (MUR)
- FONZIE project (CUP B55F21007810001)
- National Recovery and Resilience Plan (NRRP)
- Ministero dell'Università e della Ricerca
Zitieren
APA
Di Gloria, L., Baldi, S., Curini, L., Bertorello, S., Nannini, G., Cei, F., Niccolai, E., Ramazzotti, M., & Amedei, A. (2025). Experimental tests challenge the evidence of a healthy human blood microbiome. The FEBS Journal, 292(4), 796-808. https://doi.org/10.1111/febs.17362
Vancouver
Di Gloria L, Baldi S, Curini L, Bertorello S, Nannini G, Cei F, et al. Experimental tests challenge the evidence of a healthy human blood microbiome. The FEBS Journal. 2025;292(4):796-808. doi:10.1111/febs.17362
BibTeX
@article{DiGloria2025,
author = {Di Gloria, Leandro and Baldi, Simone and Curini, Lavinia and Bertorello, Sara and Nannini, Giulia and Cei, Francesco and Niccolai, Elena and Ramazzotti, Matteo and Amedei, Amedeo},
title = {Experimental tests challenge the evidence of a healthy human blood microbiome},
journal = {The FEBS Journal},
year = {2025},
volume = {292},
number = {4},
pages = {796--808},
doi = {10.1111/febs.17362}
}
EUVIMED